CompoAtlas

SunnyCa Ultra Osteo Protector

Natural health product licensed in Canada

Licence holder
Global Milex Enterprises Ltd.
NPN or DIN-HM
80020614
Status
Active licence
Licence date
7 July 2010
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Magnésium

Source : Graine(s)

175 mg350,000 µg
Silicium

Source : Plante

5 mgNot calculated
Vitamine D

Source : Cholécalciférol

Potency : 125 UI

3.125 mcg6.25 µg
Calcium

Source : Graine(s)

350 mg700,000 µg

Non-medicinal ingredients

cellulose, Pharmaceutical Glaze, Collagène hydrolysé, Dihydrate dibasique de phosphate de calcium, Stéarate de magnésium, Croscarmellose de sodium, Acide stéarique

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Compriméminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in the development and maintenance of the bones and teeth. Helps in tissue formation. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps to maintain proper muscle function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80020614

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line